Paul Stuka - 27 May 2026 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 May 2026, 16:05:10 UTC
Prior SEC filing
15 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka

Key filing fact

Paul Stuka filed Form 4 for InspireMD, Inc. (NSPR) on 29 May 2026.

Key facts

  • This page summarizes Paul Stuka's Form 4 filing for InspireMD, Inc. (NSPR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 29 May 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 15 May 2026.
  • Current net transaction value: +$17,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001528577 Primary reporting owner

Stuka Paul

Relationship
Director
Address
C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI
Signature
/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka
Signature date
29 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NSPR transaction

Common Stock

Purchase

Transaction value
$17,500
Shares
+20,000
Change %
+3.1%
Price
$0.8750
Shares after
667,871
Date
27 May 2026
Ownership
Direct
Footnotes
F1
NSPR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
423,704
Date
27 May 2026
Ownership
See Footnote
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $0.87 to $0.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Footnote F2

These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .